Abstract
Vaccination is historically one of the most important methods for preventing infectious diseases in humans and animals. New insights in the biology of the immune system allow a more rational design of vaccines, and new vaccination strategies are emerging. DNA vaccines have been proposed as a promising approach for introducing foreign antigens into the host for inducing protective immunity against infectious and cancer diseases. Nevertheless, because of their poor immunogenicity, plasmid DNA vaccination strategies need further implementations. Recent data suggest electrotransfer as a useful tool to improve DNA-based vaccination protocols, being able to stimulate both the humoral and cellular immune responses. In preclinical trials, gene electrotransfer is successfully used in prime-boost combination protocols and its tolerability and safety has been demonstrated also in Phase I clinical trials. In this chapter, we report a short comment supporting electrotransfer as an effective strategy to improve DNA-based vaccination protocols and describe the vaccination procedures by plasmid DNA in combination with electrotransfer and hyaluronidase pretreatment in use in our laboratory.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Wells DJ (2006) Viral and non-viral methods for gene transfer into skeletal muscle. Curr Opin Drug Discov Dev 9:163–168
Zhu J, Martinez J, Huang X et al (2007) Innate immunity against vaccinia virus is mediated by TLR2 and requires TLR-independent production of IFN-beta. Blood 109:619–625
Molnar-Kimber KL, Sterman DH, Chang M et al (1998) Impact of pre-existing and induced humoral and cellular immune responses in an adenovirus-based gene therapy phase I clinical trial for localized mesothelioma. Hum Gene Ther 9:2121–2133
Cohen P (2006) Immunity’s yin and yang. A successful vaccine must first avoid being eliminated by pre-existing immunity before it can promote a protective immune response. IAVI Rep 10:1–5
Ellis RW, Gerety RJ (1990) Key issues in the selection of an expression system for vaccine antigens. J Med Virol 31:54–58
Touihri L, Ahmed SB, Chtourou Y et al (2012) Design of different strategies of multivalent DNA-based vaccination against rabies and canine distemper in mice and dogs. Virol J 9:319
Li J, Jiang Y, Zhao S et al (2012) Protective efficacy of an H5N1 DNA vaccine against challenge with a lethal H5N1 virus in quail. Avian Dis 56:937–939
Fredriksen AB, Sandlie I, Bogen B (2012) Targeted DNA vaccines for enhanced induction of idiotype-specific B and T cells. Front Oncol 2:154
Signori E, Iurescia S, Massi E et al (2010) DNA vaccination strategies for anti-tumour effective gene therapy protocols. Cancer Immunol Immunother 59:1583–1591
Cho HI, Celis E (2012) Design of immunogenic and effective multi-epitope DNA vaccines for melanoma. Cancer Immunol Immunother 61:343–351
Powell K (2004) DNA vaccines: back in the saddle again? Nat Biotechnol 22:799–801
Lorenzen N, Lapatra SE (2005) DNA vaccines for aquacultured fish. Rev Sci Tech 24:201–213
Kutzler MA, Weiner DB (2008) DNA vaccines: ready for prime time. Nat Rev Genet 9:776–788
Chiarella P, Massi E, De Robertis M et al (2007) Adjuvants in vaccines and for immunisation: current trends. Expert Opin Biol Ther 7:1551–1562
Chiarella P, Massi E, De Robertis M et al (2008) Strategies for effective naked-DNA vaccination against infectious diseases. Recent Pat Antiinfect Drug Discov 3:93–101
Neumann E, Schaefer-Ridder M, Wang Y et al (1982) Gene transfer into mouse lymphoma cells by EP in high electric fields. EMBO J 1:841–845
Okino M, Mohri H (1987) Effects of a high-voltage electrical impulse and an anticancer drug on in vivo growing tumors. Jpn J Cancer Res 78:1319–321
Titomirov AV, Sukharev S, Kistanova E (1991) In vivo electroporation and stable transformation of skin cells of newborn mice by plasmid DNA. Biochim Biophys Acta 1088:131–34
Mir LM (2009) Nucleic acids electrotransfer-based gene therapy (electrogenetherapy): past, current, and future. Mol Biotechnol 43:167–176
McMahon JM, Signori E, Wells KE et al (2001) Optimisation of electrotransfer of plasmid into skeletal muscle by pretreatment with hyaluronidase—increased expression with reduced muscle damage. Gene Ther 8:1264–1270
Rosati M, Valentin A, Jalah R et al (2008) Increased immune responses in rhesus macaques by DNA vaccination combined with electroporation. Vaccine 26:5223–5229
Hirao LA, Wu L, Khan AS et al (2008) Combined effects of IL-12 and electroporation enhances the potency of DNA vaccination in macaques. Vaccine 26:3112–3120
Otten G, Schaefer M, Doe B et al (2004) Enhancement of DNA vaccine potency in rhesus macaques by electroporation. Vaccine 22:2489–2493
Aihara H, Miyazaki J (1998) Gene transfer into muscle by electroporation in vivo. Nat Biotechnol 16:867–870
Mathiesen I (1999) Electropermeabilization of skeletal muscle enhances gene transfer in vivo. Gene Ther 6:508–514
Babiuk S, Baca-Estrada ME, Foldvari M et al (2004) Increased gene expression and inflammatory cell infiltration caused by electroporation are both important for improving the efficacy of DNA vaccines. J Biotechnol 110:1–10
Widera G, Austin M, Rabussay D et al (2000) Increased DNA vaccine delivery and immunogenicity by electroporation in vivo. J Immunol 164:4635–4640
Chiarella P, Massi E, De Robertis M et al (2008) Electroporation of skeletal muscle induces danger signal release and antigen-presenting cell recruitment independently of DNA vaccine administration. Expert Opin Biol Ther 8:1645–1657
Bergqvist S (1950) Increased reaction to BCG vaccination caused by hyaluronidase. Nord Med 43:955–956
Salvioli G, Degli Esposti A, Dina MA (1952) Experimental studies on Salvioli’s diffusing vaccine; study of histobiochemical reactions in vaccination with killed Koch’s bacilli with and without hyaluronidase. Boll Ist Sieroter Milan 31:210–225
Tozuka TN, Akira Y, Yaajima T et al (1954) The enhancement of the effect of B.C.G. vaccination with hyaluronidase. J Shinshu Univ 4:39–71
Jedrzejas MJ, Stern R (2005) Structures of vertebrate hyaluronidases and their unique enzymatic mechanism of hydrolysis. Proteins 61:227–238
Stern R, Jedrzejas MJ (2006) Hyaluronidases: their genomics, structures, and mechanisms of action. Chem Rev 106:818–839
Kreil G (1995) Hyaluronidases: a group of neglected enzymes. Protein Sci 4:1666–1669
Wiegand R, Brown J (2010) Hyaluronidase for the management of dextrose extravasation. Am J Emerg Med 2:257
Rowlett J (2012) Extravasation of contrast media managed with recombinant human hyaluronidase. Am J Emerg Med 9:2102
Dubensky TW, Campbell BA, Villareal LP (1984) Direct transfection of viral and plasmid DNA into the liver or spleen of mice. Proc Natl Acad Sci U S A 81:7529–7533
Favre D, Cherel Y, Provost N et al (2000) Hyaluronidase enhances recombinant adeno-associated virus (rAAV)-mediated gene transfer in the rat skeletal muscle. Gene Ther 7:1417–1420
Chiarella P, Fazio VM, Signori E (2010) Application of electroporation in DNA vaccination protocols. Curr Gene Ther 10:281–6
Chiarella P, De Santis S, Fazio VM, Signori E (2013) Hyaluronidase contributes to the early inflammatory events induced by electrotransfer on the mouse skeletal muscle. Hum Gene Ther 24:406–16
Acknowledgments
The authors thank the staff of the Animal Facility at the “Sacro Cuore” Catholic University of Rome for their assistance in animal care.
E.S. thanks the COST Action TD1104 network-EP4Bio2Med Consortium (http://www.electroporation.net).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this protocol
Cite this protocol
Chiarella, P., Signori, E. (2014). Intramuscular DNA Vaccination Protocols Mediated by Electric Fields. In: Li, S., Cutrera, J., Heller, R., Teissie, J. (eds) Electroporation Protocols. Methods in Molecular Biology, vol 1121. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4614-9632-8_28
Download citation
DOI: https://doi.org/10.1007/978-1-4614-9632-8_28
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4614-9631-1
Online ISBN: 978-1-4614-9632-8
eBook Packages: Springer Protocols